CCL21-ICAM1 niche accelerates OT-I T-cell hits against B16 melanoma
A CCL21-ICAM1 synthetic niche sped lytic-hit delivery by OT-I T cells against B16 melanoma in vitro, but the report gives no human data or effect size.
Topic
B16 Melanoma
Topic
Topic
Topic
A CCL21-ICAM1 synthetic niche sped lytic-hit delivery by OT-I T cells against B16 melanoma in vitro, but the report gives no human data or effect size.